{"id":16588,"date":"2023-01-13T09:40:02","date_gmt":"2023-01-13T07:40:02","guid":{"rendered":"https:\/\/www.incliva.es\/el-proyecto-internacional-aida-coordinado-por-incliva-desarrollara-un-asistente-diagnostico-mediante-ia-que-permitira-detectar-lesiones-previas-al-cancer-gastrico\/"},"modified":"2023-01-13T09:40:02","modified_gmt":"2023-01-13T07:40:02","slug":"incliva-coordinated-international-project-aida-will-develop-an-ai-diagnostic-assistant-to-help-detect-lesions-before-gastric-cancer","status":"publish","type":"post","link":"https:\/\/tst.incliva.es\/en\/incliva-coordinated-international-project-aida-will-develop-an-ai-diagnostic-assistant-to-help-detect-lesions-before-gastric-cancer\/","title":{"rendered":"INCLIVA-coordinated international project AIDA will develop an AI diagnostic assistant to help detect lesions before gastric cancer"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#e2e2e2;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><style type=\"text\/css\">@media only screen and (max-width:1532px) {.fusion-title.fusion-title-1{margin-top:10px!important;margin-bottom:15px!important;}}@media only screen and (max-width:640px) {.fusion-title.fusion-title-1{margin-top:10px!important;margin-bottom:10px!important;}}<\/style><div class=\"fusion-title title fusion-title-1 fusion-sep-none fusion-title-text fusion-title-size-four\" style=\"margin-top:10px;margin-bottom:15px;\"><h4 class=\"title-heading-left\" style=\"margin:0;\"><ul>\n<li>Most gastric cancer cases are diagnosed at late stage, with life expectancy of one year<\/li>\n<li>AIDA will help guide gastric cancer prevention action, risk assessment in the presymptomatic stage, and personalized medical follow-up<\/li>\n<\/ul><\/h4><\/div><div ><span class=\" fusion-imageframe imageframe-none imageframe-1 hover-type-none\" style=\"margin-bottom:20px;\"><img src=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2023\/01\/Proyecto-AIDA-cancer-gastrico.jpg\" class=\"img-responsive\"\/><\/span><\/div><div class=\"fusion-text fusion-text-1\" style=\"transform:translate3d(0,0,0);\"><p>INCLIVA Biomedical Research Institute is coordinating an international, <strong>multicentre project to develop an Artificial Intelligence (AI)-based diagnostic assistant<\/strong> to help researchers, doctors and patients understand, diagnose and treat chronic gastric inflammation, which often precedes gastric cancer.<\/p>\n<p>The project, called <strong>AIDA<\/strong> (<strong>An Artificially Intelligent Diagnostic Assistant for gastric inflammation<\/strong>), launched this January and holding its kick-off meeting this week at INCLIVA, has a four-year duration and is supported by o<strong>ver 7 million euros between European and British funding<\/strong>.<\/p>\n<p>The project is led by <strong>Tania Fleitas<\/strong> (researcher at the INCLIVA research group in colorectal cancer and new therapeutic developments in solid tumours, and oncologist at the Hospital Cl\u00ednico Universitario de Val\u00e8ncia), <strong>with the support of INCLIVA\u2019s International Projects Unit<\/strong>. The project consortium comprises <strong>15 centres of excellence from eight European countries<\/strong>, bringing together a multidisciplinary team including some of the <strong>leading European authorities on gastric inflammation and cancer<\/strong> (areas of epidemiology, immunology, oncology, pathology and gastroenterology), experts in bioinformatics, artificial intelligence and machine learning and in data governance and privacy, representatives of the public administration and patient advocates.<\/p>\n<p><strong>Gastric cancer <\/strong>is the<strong> fifth most common cancer type and the third leading cause of cancer death in the world in both sexes<\/strong>. It affects almost one million people, and to date no strategy has improved the prognosis of the disease. It causes 783,000 deaths a year, and the survival rate for patients at an advanced stage is only about 12 months.<\/p>\n<p>Despite current multimodal treatments including surgery, chemotherapy and radiotherapy to improve loco-regional control and reduce the rate of tumour dissemination, progress is still limited, and more action is needed in primary and secondary prevention.<\/p>\n<p>Most cases of gastric cancer are detected at late stage, so diagnosing those at risk of developing gastric cancer in the presymptomatic stage could significantly improve their prognosis. A wealth of data is available on the risk factors for developing gastric cancer. Individually, none are supported by robust evidence, but combining and correlating them will provide a much clearer picture.<\/p>\n<h3><strong>AIDA: an assistant to guide strategies for gastric cancer prevention<\/strong><\/h3>\n<p>The AIDA project goal is <strong>to create an AI-powered tool to help clinicians<\/strong> diagnose precancerous inflammation, provide personalized medical follow-up, recommend action to monitor patients\u2019 health status, and select treatment. AIDA will pool together data from different sectors, including research and innovation centres, clinical partners, industry and patients, while adhering to European data protection law.<\/p>\n<p>Aside from <strong>Tania Fleitas<\/strong>, AIDA&#8217;s <strong>main researchers<\/strong> include <strong>Javier Gisbert<\/strong> from the <strong>La Princesa University Hospital in Madrid<\/strong> and <strong>Leticia Moreira<\/strong> from the <strong>Hospital Cl\u00ednic in Barcelona<\/strong>, both in Spain. Principal Investigators from other countries are <strong>Kirill Veselkov<\/strong> of <strong>Imperial College London<\/strong> (United Kingdom); <strong>Tamara Matysiak-Budnik<\/strong> from the <strong>University of Nantes<\/strong> (France); <strong>Mario Dinis-Ribeiro<\/strong>, from the <strong>Portuguese Institute of Oncology in Porto<\/strong>, and <strong>F\u00e1tima Carneiro<\/strong>, from <strong>I3S<\/strong> (Portugal); <strong>Stefano Sedola<\/strong>, from the SME <strong>Stratejai<\/strong>, and <strong>Zorana Maravic<\/strong>, from the <strong>DiCE<\/strong> patients&#8217; association (Belgium); <strong>Manon Spaander<\/strong> from the <strong>Erasmus University<\/strong>, Rotterdam (The Netherlands); <strong>Marcis Leja<\/strong>, from the <strong>University of Latvia<\/strong>; and <strong>Jonaitis Laimas<\/strong>, from the <strong>University of Lithuania<\/strong>.<\/p>\n<p>Finally, the <strong>INCLIVA research team<\/strong> comprises <strong>Ana Miralles-Marco<\/strong> (coordination and management); <strong>Carolina Mart\u00ednez-Carpaglini<\/strong> (pathology);<strong> Rosana Villagrasa<\/strong>, <strong>Pablo Navarro<\/strong> and <strong>Andr\u00e9s Pe\u00f1a<\/strong> (digestive medicine); <strong>Juan Carbonell<\/strong> (biostatistics); <strong>Pilar Rentero<\/strong> (precision medicine); <strong>Elena Jim\u00e9nez<\/strong>, <strong>Manuel Cabeza-Segura<\/strong>, <strong>Josefa Castillo<\/strong> and <strong>Andrea Mar\u00edn<\/strong> (translational laboratory); <strong>Sergio Romero<\/strong> (data management) and oncologists <strong>Valentina Gambardella<\/strong> and Andr\u00e9s Cervantes.<\/p>\n<p>AIDA is one of 13 European projects to obtain funding through the <strong>Horizon Europe program<\/strong> in the HORIZON-HLTH-2022-STAYHLTH-02-01 call for proposals, having been selected from among the 72 proposals submitted within the health cluster. Horizon Europe is the largest research and innovation program in the European Union and carries out a thorough evaluation of all submitted proposals before granting funds.<\/p>\n<p><img class=\"alignleft wp-image-16580\" src=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2023\/01\/pie-financiacion.jpg\" alt=\"\" width=\"240\" height=\"120\" \/>Funded by the European Union (grant number 101095359) and supported by the UK Research and Innovation (grant number 10058099). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.<\/p>\n<\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-0{width:100% !important;margin-top : 0px;margin-bottom : 0px;}.fusion-builder-column-0 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 1.92%;padding-bottom : 0px !important;padding-left : 0px !important;margin-left : 1.92%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-column-0{width:100% !important;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-0{width:100% !important;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><\/div><style type=\"text\/css\">.fusion-body .fusion-flex-container.fusion-builder-row-1{ padding-top : 0px;margin-top : 0px;padding-right : 0px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 0px;}<\/style><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":12,"featured_media":16584,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[180,181],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/posts\/16588"}],"collection":[{"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/comments?post=16588"}],"version-history":[{"count":0,"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/posts\/16588\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/media\/16584"}],"wp:attachment":[{"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/media?parent=16588"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/categories?post=16588"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tst.incliva.es\/en\/wp-json\/wp\/v2\/tags?post=16588"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}